AGP Executive Report
Last update: an hour agoMedical Breakthrough: Prime Medicine says the U.S. FDA has cleared its IND for PM577a, a one-time in vivo gene therapy approach for Wilson disease targeting the H1069Q mutation, with a global Phase 1/2 program now set to start in the U.S. and initial data expected in 2027. Public Health & Food Safety: EFSA cut the safe daily intake for trifluoroacetic acid (TFA) after new science links it to changes in thyroid hormone levels, adding a short-term exposure limit. Healthcare Guidance: European societies published the first pan-European interdisciplinary guidelines for managing pain in acute pancreatitis, including specific recommendations for children and pregnant women. EU Policy & Money: The European Commission approved an advance payment of €931,014 to Malta from the EU Solidarity Fund for Storm Harry recovery, with final allocations still pending. Climate & Disasters: Wildfires and extreme heat are driving mass evacuations across southern Europe, with temperatures pushing above 44C. Cybersecurity: U.S. and allied agencies warn of Russian hackers exploiting unpatched Zimbra email software to steal messages, passwords and authentication tokens without victims clicking links. Everyday Life: The ECB unveiled 10 finalist designs for new euro banknotes, and citizens will vote between themes of European culture and nature.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
